Outcomes of Influenza with Treatment in Patients with Diabetes: Subgroup Analysis of the Phase 3 CAPSTONE-2 Trial

被引：0
|
作者：
Ison, Michael G. [1 ]
Castro, Rita de Cassia [2 ]
Hurt, Aeron C. [3 ]
Ko, Jinnie [2 ]
Yau, Linda [2 ]
Kuhlbusch, Klaus [3 ]
Portsmouth, Simon [4 ]
Hayden, Frederick G. [5 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] F Hoffmann Roche Ltd, Basel, Switzerland
[4] Shionogi Inc, Florham Pk, NJ USA
[5] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 2021年 / 116卷
关键词：
influenza; diabetes; antiviral; baloxavir; oseltamivir;
D O I：
10.1016/j.metabol.2020.154624
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0157
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [31] Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial
    Inagaki, Nobuya
    Yang, Wenying
    Watada, Hirotaka
    Ji, Linong
    Schnaidt, Sven
    Pfarr, Egon
    Okamura, Tomoo
    Johansen, Odd Erik
    George, Jyothis T.
    von Eynatten, Maximilian
    Rosenstock, Julio
    Perkovic, Vlado
    Wanner, Christoph
    Cooper, Mark E.
    Alexander, John H.
    Komuro, Issei
    Nangaku, Masaomi
    DIABETOLOGY INTERNATIONAL, 2020, 11 (02) : 129 - 141
  • [32] Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial
    Nobuya Inagaki
    Wenying Yang
    Hirotaka Watada
    Linong Ji
    Sven Schnaidt
    Egon Pfarr
    Tomoo Okamura
    Odd Erik Johansen
    Jyothis T. George
    Maximilian von Eynatten
    Julio Rosenstock
    Vlado Perkovic
    Christoph Wanner
    Mark E. Cooper
    John H. Alexander
    Issei Komuro
    Masaomi Nangaku
    Diabetology International, 2020, 11 : 129 - 141
  • [33] A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS
    Bozik, Michael E.
    Mitsumoto, Hiroshi
    Brooks, Benjamin R.
    Rudnicki, Stacy A.
    Moore, Dan H.
    Zhang, Bing
    Ludolph, Albert
    Cudkowicz, Merit E.
    Van den Berg, Leonard H.
    Mather, James
    Petzinger, Thomas, Jr.
    Archibald, Donald
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2014, 15 (5-6) : 406 - 413
  • [34] Reduction in Attacks in Hereditary Angioedema (HAE) With Berotralstat is Consistent Regardless of Prior Prophylactic Treatment: A Subgroup Analysis of the Phase 3 APeX-2 Trial
    Anderson, John
    Gagnon, Remi
    Best, Jessica
    Murray, Sharon
    Iocca, Heather
    Sitz, Karl
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB23 - AB23
  • [35] The Effect of High Obesity on Outcomes of Treatment for Lumbar Spinal Conditions Subgroup Analysis of the Spine Patient Outcomes Research Trial
    McGuire, Kevin J.
    Khaleel, Mohammed A.
    Rihn, Jeffrey A.
    Lurie, Jon D.
    Zhao, Wenyan
    Weinstein, James N.
    SPINE, 2014, 39 (23) : 1975 - 1980
  • [36] Efficacy of Saxagliptin in Patients with Type 2 Diabetes: Subgroup Analysis by Sex and Age
    Regensteiner, Judith G.
    Day, Danielle
    Wortzman-Show, Genevieve
    Minervini, Gianmaria
    Barrett, Yuchen
    Wei, Cheryl
    Wu, Henry
    Reusch, Jane E. B.
    DIABETES, 2015, 64 : A316 - A316
  • [37] VIBEGRON FOR THE TREATMENT OF PATIENTS WITH DRY OVERACTIVE BLADDER: A SUBGROUP ANALYSIS FROM THE EMPOWUR TRIAL
    Staskin, David
    Frankel, Jeffrey
    Varano, Susann
    Kennelly, Michael
    Newman, Diane K.
    Rosenberg, Matt T.
    Shortino, Denise
    Jankowich, Rachael A.
    Mudd, Paul N., Jr.
    JOURNAL OF UROLOGY, 2021, 206 : E1107 - E1108
  • [38] The Impact of Diabetes on the Outcomes of Surgical and Nonsurgical Treatment of Patients in the Spine Patient Outcomes Research Trial
    Freedman, Mitchell K.
    Hilibrand, Alan S.
    Blood, Emily A.
    Zhao, Wenyan
    Albert, Todd J.
    Vaccaro, Alexander R.
    Oleson, Christina V.
    Morgan, Tamara S.
    Weinstein, James N.
    SPINE, 2011, 36 (04) : 290 - 307
  • [39] SEMAGLUTIDE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: SUBGROUP ANALYSIS OF A RANDOMIZED, PLACEBO-CONTROLLED PHASE 2 TRIAL
    Francque, Sven M.
    Kjaer, Mette Skalshoi
    Ladelund, Steen
    Okanoue, Takeshi
    Mateva, Lyudmila
    Shrestha, Ichhya
    Harrison, Stephen A.
    HEPATOLOGY, 2021, 74 : 1123A - 1124A
  • [40] Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
    Ismail-Beigi, Faramarz
    Craven, Timothy
    Banerji, Mary Ann
    Basile, Jan
    Calles, Jorge
    Cohen, Robert M.
    Cuddihy, Robert
    Cushman, William C.
    Genuth, Saul
    Grimm, Richard H., Jr.
    Hamilton, Bruce P.
    Hoogwerf, Byron
    Karl, Diane
    Katz, Lois
    Krikorian, Armand
    O'Connor, Patrick
    Pop-Busui, Rodica
    Schubart, Ulrich
    Simmons, Debra
    Taylor, Harris
    Thomas, Abraham
    Weiss, Daniel
    Hramiak, Irene
    LANCET, 2010, 376 (9739): : 419 - 430
12345